Pharma is embracing wireless, so what is your plan to stay ahead of the competition?
Mobile devices are becoming ubiquitous, and the pharmaceutical industry is no different. According to a recent survey from Accenture, the number of U.S. consumers who use wearables and mobile apps (mHealth) for managing their health has doubled in the past two years. mHealth apps are becoming a trend in clinical trials as well, as 50% of the survey responders claimed they already use, or are planning to use, mHealth apps in their clinical trials.
Leveraging mobile devices for clinical trials speeds up the time to market, and allows for far greater insight and patient interaction. With these significantly increased benefits, come new risks, such as how much data will these tools be using? Mobile carriers price their plans for their average user – typically a smartphone that uses 2 to 5 GB of data a month. What if your pharmaceutical app uses a fraction of that? What if it integrates video and uses significantly more?
We at Wireless Analytics have helped our clients face these scenarios – and instead of letting all their devices be boxed into one-size-fits-all data plan, we seek other options, such as a mobile virtual network operator (MVNO) that is flexible and caters to specific needs. Our knowledge of the mobility landscape and all the options allows pharmaceutical companies to work on the tasks they are best at while having us in their corner, bringing our years of expertise and industry relationships to bear for them.
Get in touch with us today and let us know about your mobility pain points – we are sure we can provide you with a solution that can put your company at ease.